Literature DB >> 11877774

Altered mandibular development precedes the time of palate closure in mice homozygous for disproportionate micromelia: an oral clefting model supporting the Pierre-Robin sequence.

James E Ricks1, Victoria M Ryder, Laura C Bridgewater, Bruce Schaalje, Robert E Seegmiller.   

Abstract

BACKGROUND: Development of the human craniofacial anatomy involves a number of interrelated, genetically controlled components. The complexity of the interactions between these components suggests that interference with the spaciotemporal interaction of the expanding tongue and elongating Meckel's cartilage correlates with the appearance of cleft palate. Mice homozygous for the semi-dominant Col2a1 mutation Disproportionate micromelia (Dmm), presenting at birth with both cleft palate and micrognathia, provide the opportunity to test the hypothesis that mandibular growth retardation coincides with formation of the secondary palate as predicted from our understanding of the Pierre Robin sequence. The present study was conducted in embryonic day 14 (E14) mice, 1 day before palate closure, to describe the relationship between growth of the lower jaw/tongue complex versus genotype of the embryo.
METHODS: Whole heads, isolated from E14.25, E14.5 and E14.75 wild-type and homozygous mutant embryos, were fixed in Bouin's solution, embedded in paraffin, and serially sectioned. Mid-sagittal sections, stained with toluidine blue, were used to estimate growth of both tongue and lower jaw (Meckel's cartilage length) during a 12-hr period preceding palate closure.
RESULTS: In control embryos, the largest increase in Meckel's cartilage length occurred between E14.5 and E14.75. Compared to control, the mean Meckel's cartilage length in the mutant was similar at E14.25, but was significantly less at E14.5 and E14.75. Absolute tongue size in control embryos increased linearly during this period of E14.25 to E14.75. Relative to the rapidly growing Meckel's cartilage, however, relative tongue size in control embryos actually decreased over time. Absolute tongue size in the mutant was not significantly different from that of control at any of the embryonic stages examined, however, relative tongue size in the mutant was significantly greater at E14.75 compared to control.
CONCLUSION: Mandibular growth retardation, coupled with relative macroglossia in E14 Dmm/Dmm mice, suggests that the concerted development of the palate and lower jaw complex in the mutant is aberrant. Detection of micrognathia and pseudomacroglossia in homozygotes, before the time of palate closure, supports the hypothesis that a relationship exists between growth retardation of Meckel's cartilage and malformation of the secondary palate, as predicted by the Pierre-Robin sequence. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877774     DOI: 10.1002/tera.10022

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  15 in total

1.  The heterozygous disproportionate micromelia (dmm) mouse: morphological changes in fetal cartilage precede postnatal dwarfism and compared with lethal homozygotes can explain the mild phenotype.

Authors:  Robert E Seegmiller; Brandon D Bomsta; Laura C Bridgewater; Cindy M Niederhauser; Carolina Montaño; Sterling Sudweeks; David R Eyre; Russell J Fernandes
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

2.  Specific inactivation of Twist1 in the mandibular arch neural crest cells affects the development of the ramus and reveals interactions with hand2.

Authors:  Yanping Zhang; Evan L Blackwell; Mitchell T McKnight; Gregory R Knutsen; Wendy T Vu; L Bruno Ruest
Journal:  Dev Dyn       Date:  2012-03-29       Impact factor: 3.780

Review 3.  Robin sequence: from diagnosis to development of an effective management plan.

Authors:  Kelly N Evans; Kathleen C Sie; Richard A Hopper; Robin P Glass; Anne V Hing; Michael L Cunningham
Journal:  Pediatrics       Date:  2011-04-04       Impact factor: 7.124

4.  Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton.

Authors:  Magda A Meester-Smoor; Marcel Vermeij; Marjolein J L van Helmond; Anco C Molijn; Karel H M van Wely; Arnold C P Hekman; Christl Vermey-Keers; Peter H J Riegman; Ellen C Zwarthoff
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  PRDM paralogs antagonistically balance Wnt/β-catenin activity during craniofacial chondrocyte differentiation.

Authors:  Lomeli C Shull; Ezra S Lencer; Hyun Min Kim; Susumu Goyama; Mineo Kurokawa; James C Costello; Kenneth Jones; Kristin B Artinger
Journal:  Development       Date:  2022-02-24       Impact factor: 6.868

6.  Prdm16 is required for normal palatogenesis in mice.

Authors:  Bryan C Bjork; Annick Turbe-Doan; Mary Prysak; Bruce J Herron; David R Beier
Journal:  Hum Mol Genet       Date:  2009-12-11       Impact factor: 6.150

7.  Modulation of diabetes-induced palate defects by maternal immune stimulation.

Authors:  Terry C Hrubec; Kimberly A Toops; Steven D Holladay
Journal:  Anat Rec (Hoboken)       Date:  2009-02       Impact factor: 2.064

8.  Type 1 fibroblast growth factor receptor in cranial neural crest cell-derived mesenchyme is required for palatogenesis.

Authors:  Cong Wang; Julia Yu Fong Chang; Chaofeng Yang; Yanqing Huang; Junchen Liu; Pan You; Wallace L McKeehan; Fen Wang; Xiaokun Li
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

9.  Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel's Cartilage.

Authors:  Lucie J Rochard; Irving T C Ling; Yawei Kong; Eric C Liao
Journal:  J Vis Exp       Date:  2015-10-21       Impact factor: 1.355

10.  The etiology of cleft palate formation in BMP7-deficient mice.

Authors:  Thaleia Kouskoura; Anastasiia Kozlova; Maria Alexiou; Susanne Blumer; Vasiliki Zouvelou; Christos Katsaros; Matthias Chiquet; Thimios A Mitsiadis; Daniel Graf
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.